McKesson Corporation (MCK)
NYSE: MCK
· Real-Time Price · USD
760.37
23.85 (3.24%)
At close: Sep 26, 2025, 3:59 PM
766.35
0.79%
After-hours: Sep 26, 2025, 07:51 PM EDT
McKesson Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International Segment Revenue | 3.74B | 3.46B | 3.86B | 3.71B | 3.69B | 3.55B | 3.64B | 3.48B | 3.47B | 3.36B | 4.45B | 6.24B | 6.55B | 8.53B | 9.46B | 9.11B | 9.25B | 17.15B | 9.27B | 9.54B | 1.8B | 2.21B | 2.14B | 2.06B | 1.9B | 1.96B | 2.01B | 1.95B | 1.7B | 1.44B | 1.44B | 1.56B | 1.53B | 1.38B | 1.36B | 1.46B | 1.47B | 1.36B | 1.07B | 874M | 873M | 795M | 2.38B | 760M |
| International Segment Revenue Growth | +8.00% | -10.34% | +4.07% | +0.49% | +4.03% | -2.50% | +4.72% | +0.20% | +3.12% | -24.41% | -28.67% | -4.76% | -23.22% | -9.83% | +3.85% | -1.48% | -46.09% | +84.97% | -2.80% | +429.71% | -18.32% | +2.99% | +4.13% | +8.04% | -2.66% | -2.83% | +3.29% | +14.39% | +18.26% | +0.28% | -8.18% | +2.36% | +10.80% | +1.25% | -6.84% | -0.34% | +8.11% | +26.94% | +22.31% | +0.11% | +9.81% | -66.67% | +213.82% | n/a |
| Medical-Surgical Solutions Segment Revenue | 2.7B | 2.85B | 2.95B | 2.95B | 2.64B | 2.84B | 3.03B | 2.83B | 2.61B | 2.69B | 2.99B | 2.84B | 2.59B | 2.87B | 3.08B | 3.12B | 2.53B | 2.71B | 3.05B | 2.53B | 45.06B | 46.27B | 46.92B | 45.98B | 44.16B | 40.9B | 44.28B | 41.61B | 40.98B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Medical-Surgical Solutions Segment Revenue Growth | -5.33% | -3.26% | +0.03% | +11.84% | -7.08% | -6.40% | +6.95% | +8.54% | -2.90% | -9.95% | +5.03% | +9.68% | -9.81% | -6.75% | -1.34% | +23.58% | -6.75% | -11.23% | +20.57% | -94.38% | -2.62% | -1.38% | +2.05% | +4.11% | +7.99% | -7.64% | +6.41% | +1.54% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Prescription Technology Solutions Revenue | 1.43B | 1.34B | 1.37B | 1.26B | 1.24B | 1.18B | 1.21B | 1.14B | 1.24B | 1.18B | 1.12B | 1.02B | 1.07B | 1.02B | 1.03B | 932M | 881M | 1.45B | 777M | 668M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Prescription Technology Solutions Revenue Growth | +7.09% | -2.33% | +8.38% | +1.93% | +5.17% | -2.07% | +5.70% | -8.36% | +5.25% | +5.44% | +10.12% | -4.50% | +4.51% | -1.07% | +10.62% | +5.79% | -39.03% | +85.97% | +16.32% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| U.S. Pharmaceutical Segment Revenue | 89.95B | 83.17B | 87.11B | 85.73B | 71.72B | 68.79B | 73.02B | 69.77B | 67.16B | 61.68B | 61.93B | 60.06B | 56.95B | 53.68B | 55.04B | 53.41B | 50.02B | 46.65B | 49.49B | 48.07B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| U.S. Pharmaceutical Segment Revenue Growth | +8.16% | -4.53% | +1.61% | +19.54% | +4.25% | -5.80% | +4.67% | +3.88% | +8.89% | -0.42% | +3.12% | +5.46% | +6.09% | -2.48% | +3.05% | +6.78% | +7.22% | -5.75% | +2.97% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|
| International Segment Revenue | 8.55B | 9.75B | 9.86B | 9.32B | 9.41B | 9.32B | 9.69B | 9.3B | 9.72B |
| International Segment Revenue Growth | -12.30% | -1.15% | +5.77% | -0.88% | +0.93% | -3.77% | +4.13% | -4.28% | n/a |
| United States Revenue | 47.13B | 48.79B | 49.31B | 48.29B | 46.32B | 43.11B | 46.52B | 43.77B | 42.89B |
| United States Revenue Growth | -3.40% | -1.06% | +2.11% | +4.26% | +7.45% | -7.34% | +6.28% | +2.06% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.2B | 1.88B | 1.93B | 2.4B | 1.9B | 2.09B | 2.41B | 2B | 1.77B | 1.87B | 1.82B | 1.86B | 1.87B | 2.43B | 2.99B | 2.54B | 2.09B | 2.05B | 2.11B | 2.05B | 1.91B | 1.9B | 2.42B | 2.08B | 2.02B | 2.02B | 2.03B | 1.91B | 2B | 2.11B | 1.79B | 1.88B | 1.83B | 1.98B | 1.8B | 1.75B | 1.94B | 1.91B | 1.95B | 1.89B | 1.92B | 2.07B |
| Selling, General, and Administrative Revenue Growth | +16.56% | -2.53% | -19.49% | +26.70% | -9.37% | -13.20% | +20.45% | +12.68% | -4.88% | +2.75% | -2.47% | -0.53% | -23.06% | -18.55% | +17.51% | +21.39% | +2.05% | -2.89% | +2.92% | +7.37% | +0.79% | -21.68% | +16.55% | +2.97% | -0.10% | -0.69% | +6.38% | -4.64% | -4.89% | +17.70% | -4.89% | +2.67% | -7.23% | +9.65% | +3.32% | -9.82% | +1.36% | -2.20% | +3.28% | -1.41% | -7.26% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 392M | n/a | n/a | n/a | 392M |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a |